Canada markets closed

Zymeworks Inc. (ZYME.TO)

Toronto - Toronto Delayed Price. Currency in CAD
Add to watchlist
33.10+0.53 (+1.63%)
At close: 3:58PM EDT
Full screen
Previous Close32.57
Open33.05
Bid33.04 x 0
Ask33.14 x 0
Day's Range32.77 - 33.53
52 Week Range32.77 - 33.53
Volume5,350
Avg. Volume5,400
Market Cap1.3B
Beta (5Y Monthly)1.05
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
All
News
Press Releases
  • Zymeworks Reports 2020 Year-End Financial Results
    Business Wire

    Zymeworks Reports 2020 Year-End Financial Results

    Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today reported financial results for the year ended December 31, 2020 and provided a summary of recent business and clinical highlights.

  • Zymeworks to Participate in Upcoming Investor Conferences and Events
    Business Wire

    Zymeworks to Participate in Upcoming Investor Conferences and Events

    Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, announced today that management will participate in five upcoming virtual investor conferences.

  • Zymeworks Expands Commercial Team and Creates New R&D Role
    Business Wire

    Zymeworks Expands Commercial Team and Creates New R&D Role

    Zymeworks Inc. (NYSE: ZYME), a clinical-stage biopharmaceutical company developing multifunctional biotherapeutics, today announced that James Priour, former Senior Vice President, Commercial, has been promoted to Chief Commercial Officer and named to the Company’s Executive Committee. The Commercial team also recently expanded its leadership with the addition of Manny Duenas as Vice President, Global Value & Access. Zymeworks also announced that John Babcook, former head of Discovery Research, will move into a newly created Distinguished Fellow role. Senior Vice President of Research Guowei Fang, Ph.D. will take on leadership of Discovery Research.